National Enzyme buys Sora Laboratories
This article was originally published in The Tan Sheet
The Forsyth, Mo.-based dietary supplement developer improves its ability to identify raw materials and test their quality and potency in-house with the acquisition of Sora Laboratories. The 600-square-foot full-service, analytical, microbiological and characteristics lab includes instruments to conduct detailed tests and in-depth analyses, National Enzyme Co. announced July 2. "With questionable raw material suppliers existing and adulterated products popping up, it is essential for a manufacturer to have the ability to accurately identify all that passes through their doors," the firm says. The firm intends to become ISO certified by fall 2010
You may also be interested in...
With the rapid global spread of the coronavirus, Medtech Insight looks at the predicted economic impact of the outbreak on the industry’s biggest businesses.
The European Medicines Agency says that Shionogi’s novel antibiotic, Fetcroja, should be approved for use across Europe but that Lilly's migraine drug, Emgality, should not be authorized for the extended indication of episodic cluster headache.
Despite the life sciences industry’s call for continued alignment of medicines regulation with the EU from next year and for some sort of co-operation with the European Medicines Agency, it seems the UK government is prepared to make only small concessions.